Lymph Nodes News and Research

RSS

New 'micro-organ' within the immune system identified

For the first time in decades, researchers have identified a new 'micro-organ' within the immune system - and they say it's an important step towards understanding how to make better vaccines.

22 Aug 2018

Brain tumors trap immune cells needed to fight cancer in the bone marrow, finds research

Certain brain cancers are associated with low numbers of immune system T-cells circulating in the peripheral blood. Low T-cell numbers can be a side-effect of cancer treatment. But it now appears that there is more to the story of these missing T-cells.

20 Aug 2018

Cianna Medical receives FDA 510(k) clearance to extend indication of SCOUT reflector for use in soft tissue localization

Cianna Medical, Inc., the world leader in wire-free breast localization, announced that it has received 510(k) clearance from the U.S. Food and Drug Administration to extend the indication of its SCOUT reflector for use in localization of soft tissue.

10 Aug 2018

FDA approves drug for rare, hard-to-treat types of non-Hodgkin lymphoma

The U.S. Food and Drug Administration today approved Poteligeo (mogamulizumab-kpkc) injection for intravenous use for the treatment of adult patients with relapsed or refractory mycosis fungoides or Sézary syndrome after at least one prior systemic therapy.

8 Aug 2018

Researchers use PET tracer to identify ER expression differences in metastatic breast cancer patients

In metastatic breast cancer, prognosis and treatment is largely influenced by estrogen receptor expression of the metastases.

7 Aug 2018

Beckman Coulter introduces expanded range of clinical flow cytometry solutions at AACC 2018

Beckman Coulter continues to expand portfolio of clinical flow cytometry solutions with its latest innovations.

From Beckman Coulter Life Sciences - Flow Cytometry 30 Jul 2018

Research findings may offer new path to treat or prevent neurodegenerative diseases

Aging vessels connecting the brain and the immune system play critical roles in both Alzheimer's disease and the decline in cognitive ability that comes with time, new research reveals.

26 Jul 2018

New research highlights value of free skin cancer screening program

While skin cancer can be deadly, it is also highly treatable when detected early. In fact, melanoma, the deadliest form of skin cancer, has a five-year survival rate of 95 percent when detected and treated before it spreads to the lymph nodes; conversely, the five-year survival rates for regional and distant stage melanomas are 64 percent and 23 percent, respectively.

26 Jul 2018

Patients with colon cancers on the right side have worse survival rates than those with left-sided tumors

Patients with colorectal cancer tumors on the right side may have poorer five-year survival rates than those whose tumors are located on the left side.

24 Jul 2018

Researchers shed light on risks presented by residual disease for younger breast cancer patients

A new study from the Stanford Cancer Institute finds that young women who are treated with chemotherapy for breast cancer but have residual tumor in either the breast or lymph nodes have higher chances of recurrence compared to those with no evidence of any residual invasive tumor (pathologic complete response).

23 Jul 2018

Clinical trial tests one-time, high-dose radiation treatment for early-stage breast cancer

For 81-year-old Marilyn Gibson, it was a no-brainer: Would she be interested in having a single dose of radiation to treat her breast cancer instead of the standard, multiple-dose treatment delivered over several weeks?

23 Jul 2018

Karius Test accurately detects invasive fungal infections, shows study

Karius, a life sciences company transforming infectious disease diagnostics with genomics and data through the innovative use of next-generation sequencing to analyze microbial cell-free DNA, announced today the positive results of a clinical study using blood samples from patients with confirmed invasive fungal infections.

20 Jul 2018

Imaging techniques may help assess immune system recovery in HIV patients

Findings from an animal study suggest that a non-invasive imaging technique could, with further development, become a useful tool to assess immune system recovery in people receiving treatment for HIV infection.

13 Jul 2018

Protein complex that helps shape destiny of developing T cells identified

Like a mentor helping medical students choose between specialties, a protein complex helps shape the destiny of developing T cells, St. Jude Children's Research Hospital scientists have reported.

9 Jul 2018

KU Cancer Center launches clinical trial to eliminate radiation therapy for HER2-positive breast cancer

Researchers at The University of Kansas Cancer Center have launched a clinical trial that eliminates radiation from the treatment protocol for an invasive type of breast cancer that accounts for one-fifth of all breast cancer patients.

30 Jun 2018

Summer is good time to check for signs of skin cancer

Summer time means shorts, tank tops, bathing suits – in other words, lots of exposure to the damaging UV rays of the sun. With more skin exposed, now is an especially good time to check for signs of skin cancer.

21 Jun 2018

Biotheranostics presents key data for CancerTYPE ID and Breast Cancer Index at ASCO 2018

Biotheranostics, Inc. announces new data from studies for both of its proprietary molecular diagnostic tests, CancerTYPE ID and Breast Cancer Index to be presented on Saturday, June 2nd and Monday, June 4th at the annual meeting of the American Society of Clinical Oncology in Chicago.

8 Jun 2018

Machine learning approach can accurately detect lymphedema among breast cancer survivors

Machine learning using real-time symptom reports can accurately detect lymphedema, a distressing side effect of breast cancer treatment that is more easily treated when identified early, finds a new study led by NYU Rory Meyers College of Nursing and published in the journal mHealth.

7 Jun 2018

Understanding cancer heterogeneity may help avoid harmful effects of chemotherapy

"Understanding cancer heterogeneity could further reduce chemo use," says cancer research expert Antonio Giordano, MD, PhD, Director of the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University. "Further study of cases that can successfully be treated with hormone- and immunotherapy, and how to identify them, will unlock this potential."